Curio

Curio develops nuclear waste recycling technologies to commercialize the case for a closed fuel cycle. Its technologies are used to produce proliferation hardened plutonium fueled reactors and molten salt reactors and develop unique isotopes for use in targeted therapy of cancer to help businesses avail clean energy, substantially lower environmental footprint, and advanced medicine. By addressing environmental, security, and market concerns, the company aims to establish clean nuclear power as a catalyst for global prosperity and sustainability.